Date | Time | Source | Headline | Symbol | Company |
07/12/2016 | 1:50AM | PR Newswire (US) | Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celat... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
07/12/2016 | 1:50AM | PR Newswire (US) | Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celat... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
07/07/2016 | 6:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
07/07/2016 | 6:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
07/06/2016 | 5:28PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
07/06/2016 | 5:20PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
07/01/2016 | 5:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/30/2016 | 6:06AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/29/2016 | 4:23PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/27/2016 | 6:27AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/27/2016 | 6:07AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/27/2016 | 12:10AM | PR Newswire (US) | Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/27/2016 | 12:09AM | PR Newswire (US) | Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/22/2016 | 3:45PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/22/2016 | 3:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/22/2016 | 2:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/17/2016 | 8:00AM | PR Newswire (US) | Drugs - Generic Stocks Technical Data - Allergan, Mylan, Horizon Pharma, and Celator Pharma | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/15/2016 | 5:06PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/14/2016 | 9:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/14/2016 | 7:00AM | PR Newswire (US) | Celator Pharmaceuticals® Announces Positive Results in Patients with FLT3 Mutation from the Phase 3 Trial in High-Risk Acute... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/13/2016 | 7:00PM | Business Wire | INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourage... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/10/2016 | 4:07PM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/10/2016 | 4:03PM | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/06/2016 | 5:13PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/06/2016 | 7:00AM | PR Newswire (US) | Celator Pharmaceuticals® Presented Phase 3 Trial Results in Patients with High-Risk Acute Myeloid Leukemia Demonstrating VYX... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/03/2016 | 6:21PM | PR Newswire (US) | Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX Shareholders | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/02/2016 | 1:21PM | Business Wire | CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to J... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/02/2016 | 9:11AM | PR Newswire (US) | SHAREHOLDER ALERT: Law Offices of Marc S. Henzel Announces Investigation into the proposed sales and mergers of American Capi... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/01/2016 | 11:18AM | Business Wire | CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
06/01/2016 | 10:44AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |